1. Home
  2. BANX vs DERM Comparison

BANX vs DERM Comparison

Compare BANX & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BANX

ArrowMark Financial Corp.

N/A

Current Price

$19.48

Market Cap

202.4M

Sector

Finance

ML Signal

N/A

Logo Journey Medical Corporation

DERM

Journey Medical Corporation

N/A

Current Price

$5.17

Market Cap

190.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BANX
DERM
Founded
N/A
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
202.4M
190.3M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
BANX
DERM
Price
$19.48
$5.17
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $13.75
AVG Volume (30 Days)
26.4K
★ 184.1K
Earning Date
01-01-0001
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 34.72
EPS
★ N/A
N/A
Revenue
N/A
★ $61,858,000.00
Revenue This Year
N/A
$25.29
Revenue Next Year
N/A
$50.00
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 10.20
52 Week Low
$18.45
$4.31
52 Week High
$22.50
$9.56

Technical Indicators

Market Signals
Indicator
BANX
DERM
Relative Strength Index (RSI) 42.48 40.61
Support Level $19.31 $4.79
Resistance Level $19.78 $5.50
Average True Range (ATR) 0.31 0.31
MACD -0.00 0.05
Stochastic Oscillator 44.70 39.67

Price Performance

Historical Comparison
BANX
DERM

About BANX ArrowMark Financial Corp.

ArrowMark Financial Corp is a non-diversified, closed-end management investment company. The Fund's objective is to provide stockholders with current income, and to a lesser extent capital appreciation. The company's investments in various portfolios such as debt securities, Trust Preferred and Preferred Securities, preferred securities, exchange-traded funds, money market funds and others.

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

Share on Social Networks: